InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Silver Gabrielle Alison, Director. Officer active across 1 companies, notably Opiant Pharmaceuticals, INC.. Cumulatively, 6 reports have been logged. Total volume traded: €32k. The latest transaction was disclosed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
02,000 shares0
Common Stock
SEC:0001385508-22-000082:0·
€31,8232,500 shares@ €12.729284.0% of flow
Common Stock
SEC:0001385508-22-000062:0·
Ideal exit: 10 Feb 2023 (T+270)
02,000 shares0
Common Stock
SEC:0001385508-21-000085·
02,000 shares0
Common Stock
SEC:0001385508-21-000085:0·
€3,022365 shares@ €8.28100.0% of flow
Common Stock
SEC:0001385508-21-000071·
€3,022365 shares@ €8.288.0% of flow
Common Stock
SEC:0001385508-21-000071:0·
6 of 6 declarations
About Silver Gabrielle Alison
Gabrielle Alison Silver is a Director at Opiant Pharmaceuticals, Inc. She actively participates in board discussions, bringing her expertise in the pharmaceutical field. Gabrielle contributes to the company's strategy and oversight of product development initiatives.
